PGEN

Precigen Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 1/10
  • Value↓ 0/10
Precigen sales and earnings growth
PGEN Growth
Low
  • Revenue Y/Y↑ 524.83%
  • EPS Y/Y↓ -110.71%
  • FCF Y/Y↓ -55.52%
Precigen gross and profit margin trends
PGEN Profitability
Neutral
  • Gross margin ↑ 80.10%
  • EPS margin↓ -1213.50%
  • ROIC 5Y↓ -216.57%
Precigen net debt vs free cash flow
PGEN Risk
Poor
  • Debt / Equity↑ 4.9
  • Debt / FCF↓ 0.8
  • Interest coverage↓ -29.2

Precigen stock volatility is higher than the overall market. We give it a Poor risk rating.

↗ More Biotechnology stocks